Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical benefit of range uncertainty reduction in proton treatment planning based on dual-energy CT for neuro-oncological patients.
Taasti VT, Decabooter E, Eekers D, Compter I, Rinaldi I, Bogowicz M, van der Maas T, Kneepkens E, Schiffelers J, Stultiens C, Hendrix N, Pijls M, Emmah R, Fonseca GP, Unipan M, van Elmpt W. Taasti VT, et al. Among authors: rinaldi i. Br J Radiol. 2023 Sep;96(1149):20230110. doi: 10.1259/bjr.20230110. Epub 2023 Jul 26. Br J Radiol. 2023. PMID: 37493227 Free PMC article.
Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy.
Peters N, Trier Taasti V, Ackermann B, Bolsi A, Vallhagen Dahlgren C, Ellerbrock M, Fracchiolla F, Gomà C, Góra J, Cambraia Lopes P, Rinaldi I, Salvo K, Sojat Tarp I, Vai A, Bortfeld T, Lomax A, Richter C, Wohlfahrt P. Peters N, et al. Among authors: rinaldi i. Radiother Oncol. 2023 Jul;184:109675. doi: 10.1016/j.radonc.2023.109675. Epub 2023 Apr 19. Radiother Oncol. 2023. PMID: 37084884 Free PMC article.
Evaluating and reporting LET and RBE-weighted dose in proton therapy for glioma - The Dutch approach.
Wagenaar D, Habraken SJM, Rinaldi I, Eekers DBP, Kramer M, Jaspers JPM, van Gent D, Barazzuol L, Klaver YLB, Zindler J, Coremans I, Compter I, Scandurra D, van der Weide HL, Both S, Hoogeman M, Unipan M, Méndez Romero A. Wagenaar D, et al. Among authors: rinaldi i. Radiother Oncol. 2025 Jan;202:110653. doi: 10.1016/j.radonc.2024.110653. Epub 2024 Nov 26. Radiother Oncol. 2025. PMID: 39603511 Free article.
Response to "Letter regarding Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy".
Peters N, Taasti VT, Ackermann B, Bolsi A, Dahlgren CV, Ellerbrock M, Fracchiolla F, Gomà C, Góra J, Lopes PC, Rinaldi I, Salvo K, Tarp IS, Vai A, Bortfeld T, Lomax A, Richter C, Wohlfahrt P. Peters N, et al. Among authors: rinaldi i. Radiother Oncol. 2024 Jan;190:109961. doi: 10.1016/j.radonc.2023.109961. Epub 2023 Oct 21. Radiother Oncol. 2024. PMID: 37871749 No abstract available.
Unraveling the Protective Role of Oleocanthal and Its Oxidation Product, Oleocanthalic Acid, against Neuroinflammation.
Barbalace MC, Freschi M, Rinaldi I, Zallocco L, Malaguti M, Manera C, Ortore G, Zuccarini M, Ronci M, Cuffaro D, Macchia M, Hrelia S, Giusti L, Digiacomo M, Angeloni C. Barbalace MC, et al. Among authors: rinaldi i. Antioxidants (Basel). 2024 Sep 3;13(9):1074. doi: 10.3390/antiox13091074. Antioxidants (Basel). 2024. PMID: 39334733 Free PMC article.
150 results